Revenue growth accelerating as new sales initiatives and expanded team gain traction NEW HAVEN, CT, [...]
Ultra-sensitive enrichment reagent enables development of low cost detection tests, allowing optimized patient treatment NEW [...]
Growth resulting from commercial team reorganization, product and service cross-selling, and increased business stabilization NEW [...]
NEW HAVEN, CT, (April 26th, 2018) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), provides details of [...]
Management focuses on growth opportunities NEW HAVEN, CT, (April 23rd, 2018) – Specialty cancer diagnostics company Precipio, [...]
NEW HAVEN, CT, (April 18th, 2018) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today it [...]
Management to provide strategic business update to shareholders NEW HAVEN, CT, (April 17th, 2018) – Specialty [...]
Complimentary Precipio ICE COLD PCR™ reagents now available to advance body of research and accelerate [...]
Study cites major accuracy flaws in predominant liquid biopsy platforms offered by competitors NEW HAVEN, [...]
In collaboration with Yale, feminine panty liner designed to remove obstacles to early detection NEW [...]
No products in the cart.
Return to shop
Username or email address *
Remember me Log in
Lost your password?